PAPER Ratner MH

A critical review of the interrelationships between genetics, neurotoxicant exposure, and age at onset of neurodegenerative diseases

Current Topics in Toxicology. 2016; (12):1-10. Embase PUI: L616391802 .

PAPER Saunders AJ, Kim TW, Tanzi RE

BACE maps to chromosome 11 and a BACE homolog, BACE2, reside in the obligate Down’s syndrome region of chromosome 21

Science 1999 Nov 12;(286):1255a. .

PAPER Dudau M, Frumosu M, Codrici E, Tanase C, Ana-Maria E

Arguments for caveolin-1 knock-out mice as an Alzheimer’s disease model

Austin Alzheimers J Parkinsons Dis. June 2, 2016 .

PAPER Reimand J, Collij L, Scheltens P, Bouwman F, Ossenkoppele R

Amyloid-beta CSF/PET discordance vs tau load 5 years later: It takes two to tangle

medRxiv February 3, 2020. .

PAPER Peterschmitt MJ, Gasser T, Isaacson S, Kulisevsky J, Mir P, Simuni T, Wills AM, Guedes LC, Svenningsson P P, Waters C, Ji AJ, Li J, Minini P, Nembo B, Saubadu S, Sharma J, Fischer T

Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation

Science Direct February 2019 .

PAPER Porter T, Villemagne V, Savage G, Milicic L, Lim YY, Maruff P, Masters CL, Ames D, Bush AI, Rainey-Smith S, Rowe CC, Groth D, Martins RN, Verdile G, Burnham SC, Laws SM, for the AIBL research group

Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease

Personalized Medicine in Psychiatry, March–April 2018 .

PAPER Maes T, Mascaró C, Rotllant D, Cavalcanti F, Carceller E, Ortega A, Molinero C, Buesa C

P4‐404: Ory‐2001: An Epigenetic Drug for the Treatment of Cognition Defects in Alzheimer’S Disease and Other Neurodegenerative Disorders

Alzheimer's & Dementia, July 27, 2016 .

PAPER Kaniyappan S, Tepper K, Biernat J, Chandupatla RR, Hübschmann S, Irsen S, Bicher S, Klatt C, Mandelkow EM, Mandelkow E

FRET-based tau seeding assay does not represent prion-like templated assembly of tau fibers.

bioRxiv March 25, 2020. . BioRxiv.

PAPER Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, Matsubara T, Tomita T, Ando T, Hasegawa K, Murayama S, Yoshida M, Hasegawa M, Scheres SH, Goedert M

Structures of α-synuclein filaments from multiple system atrophy

bioXriv, February 6, 2020 .

PAPER Maguire E, Menzies GE, Phillips T, Sasner M, Williams HM, Czubala MA, Evans N, Cope EL, Sims R, Howell GR, Lloyd-Evans E, Williams J, Allen ND, Taylor PR

The Alzheimer’s disease protective P522R variant of PLCG2, consistently enhances stimulus-dependent PLCγ2 activation, depleting substrate and altering cell function

bioRxiv, April 28, 2020 .

PAPER Tsai AP, Dong C, Preuss C, Moutinho M, Lin PB, Hajicek N

PLCG2 as a Risk Factor for Alzheimer’s Disease

bioRxiv: 2020.2005.2019.104216. . BioRxiv.

PAPER Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, Zhang X, Xue Y, Maimon R, Dowdy SF, Devaraj NK, Zhou Z, Mobley WC, Cleveland DW, Fu XD

Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Nature, June 24, 2020 .

PAPER Munji RN, Daneman R

Young brains welcome protein

Nature. 2020 Jul 1. .

PAPER Alić I, Goh PA, Murray A, Portelius E, Gkanatsiou E, Gough G, Mok KY, Koschut D, Brunmeir R, Yeap YJ, O'Brien NL, Groet J, Shao X, Havlicek S, Dunn NR, Kvartsberg H, Brinkmalm G, Hithersay R, Startin C, Hamburg S, Phillips M, Pervushin K, Turmaine M, Wallon D, Rovelet-Lecrux A, Soininen H, Volpi E, Martin JE, Foo JN, Becker DL, Rostagno A, Ghiso J, Krsnik Ž, Šimić G, Kostović I, Mitrečić D, LonDownS Consortium, Francis PT, Blennow K, Strydom A, Hardy J, Zetterberg H, Nižetić D

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene-dose-sensitive AD-suppressor in human brain

Mol Psychiatry. 2021 Oct;26(10):5766-5788. Epub 2020 Jul 10 PubMed. bioRxiv

PAPER

Rotigotine

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, Jul 21, 2017 .